Valeria Leuci

889 total citations
27 papers, 542 citations indexed

About

Valeria Leuci is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Valeria Leuci has authored 27 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 15 papers in Immunology and 6 papers in Molecular Biology. Recurrent topics in Valeria Leuci's work include CAR-T cell therapy research (23 papers), Immune Cell Function and Interaction (12 papers) and Immunotherapy and Immune Responses (9 papers). Valeria Leuci is often cited by papers focused on CAR-T cell therapy research (23 papers), Immune Cell Function and Interaction (12 papers) and Immunotherapy and Immune Responses (9 papers). Valeria Leuci collaborates with scholars based in Italy, United States and Austria. Valeria Leuci's co-authors include Dario Sangiolo, Massimo Aglietta, Loretta Gammaitoni, Giulia Mesiano, Lidia Giraudo, Fabrizio Carnevale‐Schianca, Maja Todorovic, Wanda Piacibello, Franca Fagioli and Ramona Rotolo and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Valeria Leuci

27 papers receiving 537 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Valeria Leuci Italy	14	405	347	127	66	42	27	542
Stephanie Silveria United States	5	328 0.8×	472 1.4×	223 1.8×	84 1.3×	30 0.7×	6	723
Deborah Joseph-Pietras United Kingdom	6	362 0.9×	290 0.8×	126 1.0×	44 0.7×	47 1.1×	9	497
Sabine Stienen Germany	13	491 1.2×	307 0.9×	148 1.2×	46 0.7×	51 1.2×	26	639
Kevin M. Friedman United States	8	405 1.0×	283 0.8×	193 1.5×	55 0.8×	23 0.5×	15	530
Karan Kohli United States	8	337 0.8×	395 1.1×	135 1.1×	36 0.5×	57 1.4×	10	607
Alexander Biederstädt Germany	5	375 0.9×	402 1.2×	155 1.2×	45 0.7×	44 1.0×	9	604
Marie Boutet France	8	381 0.9×	473 1.4×	96 0.8×	35 0.5×	28 0.7×	11	618
Amy K. Erbe United States	15	329 0.8×	314 0.9×	100 0.8×	27 0.4×	42 1.0×	55	525
Jonathan J. Hodgins Canada	5	530 1.3×	631 1.8×	150 1.2×	26 0.4×	55 1.3×	7	803
Sanaz Taromi Germany	9	305 0.8×	139 0.4×	156 1.2×	62 0.9×	30 0.7×	13	422

Countries citing papers authored by Valeria Leuci

Since Specialization

Citations

This map shows the geographic impact of Valeria Leuci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Valeria Leuci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Valeria Leuci more than expected).

Fields of papers citing papers by Valeria Leuci

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Valeria Leuci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Valeria Leuci. The network helps show where Valeria Leuci may publish in the future.

Co-authorship network of co-authors of Valeria Leuci

This figure shows the co-authorship network connecting the top 25 collaborators of Valeria Leuci. A scholar is included among the top collaborators of Valeria Leuci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Valeria Leuci. Valeria Leuci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vitali, Letizia, Annamaria Massa, Alessandra Merlini, et al.. (2025). Abstract 2159: B7-H3 as a strategic target for CAR-CIK immunotherapy to eliminate chemoresistant cancer stem cells across diverse tumor histotypes. Cancer Research. 85(8_Supplement_1). 2159–2159. 1 indexed citations

Petti, Consalvo, Valeria Leuci, Simonetta M. Leto, et al.. (2024). Preclinical efficacy of a HER2 synNotch/CEA-CAR combinatorial immunotherapy against colorectal cancer with HER2 amplification. Molecular Therapy. 32(8). 2741–2761. 13 indexed citations

Leuci, Valeria, Annamaria Massa, Ramona Rotolo, et al.. (2024). Three-dimensional dynamics of mesothelin-targeted CAR.CIK lymphocytes against ovarian cancer peritoneal carcinomatosis. Cancer Immunology Immunotherapy. 74(1). 6–6. 2 indexed citations

Rotolo, Ramona, Annamaria Massa, Alessandra Merlini, et al.. (2023). PD-1 receptor outside the main paradigm: tumour-intrinsic role and clinical implications for checkpoint blockade. British Journal of Cancer. 129(9). 1409–1416. 7 indexed citations

Chiriaco, Cristina, Stefano Ughetto, Chiara Modica, et al.. (2022). Efficacy of CAR-T immunotherapy in MET overexpressing tumors not eligible for anti-MET targeted therapy. Journal of Experimental & Clinical Cancer Research. 41(1). 309–309. 15 indexed citations

Giordano, G, Alessandra Merlini, Giulio Ferrero, et al.. (2021). EphA2 Expression in Bone Sarcomas: Bioinformatic Analyses and Preclinical Characterization in Patient-Derived Models of Osteosarcoma, Ewing’s Sarcoma and Chondrosarcoma. Cells. 10(11). 2893–2893. 20 indexed citations

Pignochino, Ymera, Giovanni Crisafulli, G Giordano, et al.. (2021). PARP1 Inhibitor and Trabectedin Combination Does Not Increase Tumor Mutational Burden in Advanced Sarcomas—A Preclinical and Translational Study. Cancers. 13(24). 6295–6295. 2 indexed citations

Rotolo, Ramona, et al.. (2021). Cellular Immunotherapy Targeting Cancer Stem Cells: Preclinical Evidence and Clinical Perspective. Cells. 10(3). 543–543. 19 indexed citations

Rotolo, Ramona, Valeria Leuci, Loretta Gammaitoni, et al.. (2019). CAR-Based Strategies beyond T Lymphocytes: Integrative Opportunities for Cancer Adoptive Immunotherapy. International Journal of Molecular Sciences. 20(11). 2839–2839. 34 indexed citations

10.

Sanlorenzo, Martina, Igor Vujic, Mauro Novelli, et al.. (2018). BRAF and MEK Inhibitors Increase PD-1-Positive Melanoma Cells Leading to a Potential Lymphocyte-Independent Synergism with Anti–PD-1 Antibody. Clinical Cancer Research. 24(14). 3377–3385. 30 indexed citations

11.

Leuci, Valeria, Federica Maione, Ramona Rotolo, et al.. (2016). Lenalidomide normalizes tumor vessels in colorectal cancer improving chemotherapy activity. Journal of Translational Medicine. 14(1). 119–119. 17 indexed citations

12.

Leuci, Valeria, Giulia Mesiano, Loretta Gammaitoni, et al.. (2014). Ex Vivo-Activated MHC-Unrestricted Immune Effectors for Cancer Adoptive Immunotherapy. Anti-Cancer Agents in Medicinal Chemistry. 14(2). 211–222. 2 indexed citations

13.

Mesiano, Giulia, Valeria Leuci, Lidia Giraudo, et al.. (2014). Adoptive immunotherapy against sarcomas. Expert Opinion on Biological Therapy. 15(4). 517–528. 10 indexed citations

14.

Leuci, Valeria, Giulia Mesiano, Loretta Gammaitoni, Massimo Aglietta, & Dario Sangiolo. (2014). Genetically Redirected T Lymphocytes for Adoptive Immunotherapy of Solid Tumors. Current Gene Therapy. 14(1). 52–62. 15 indexed citations

15.

Gammaitoni, Loretta, Valeria Leuci, Giulia Mesiano, et al.. (2014). Immunotherapy of cancer stem cells in solid tumors: initial findings and future prospective. Expert Opinion on Biological Therapy. 14(9). 1259–1270. 18 indexed citations

16.

Gammaitoni, Loretta, Lidia Giraudo, Valeria Leuci, et al.. (2013). Effective Activity of Cytokine-Induced Killer Cells against Autologous Metastatic Melanoma Including Cells with Stemness Features. Clinical Cancer Research. 19(16). 4347–4358. 80 indexed citations

17.

Mesiano, Giulia, Maja Todorovic, Loretta Gammaitoni, et al.. (2012). Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors. Expert Opinion on Biological Therapy. 12(6). 673–684. 122 indexed citations

18.

Todorovic, Maja, Giulia Mesiano, Loretta Gammaitoni, et al.. (2012). Ex Vivo Allogeneic Stimulation Significantly Improves Expansion of Cytokine-Induced Killer Cells Without Increasing Their Alloreactivity Across HLA Barriers. Journal of Immunotherapy. 35(7). 579–586. 20 indexed citations

19.

Leuci, Valeria, Giulia Mesiano, Loretta Gammaitoni, et al.. (2011). Transient proteasome inhibition as a strategy to enhance lentiviral transduction of hematopoietic CD34+ cells and T lymphocytes: Implications for the use of low viral doses and large-size vectors. Journal of Biotechnology. 156(3). 218–226. 13 indexed citations

20.

Sangiolo, Dario, Valeria Leuci, Susanna Gallo, Massimo Aglietta, & Wanda Piacibello. (2011). Gene-modified T lymphocytes in the setting of hematopoietic cell transplantation: potential benefits and possible risks. Expert Opinion on Biological Therapy. 11(5). 655–666. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact